Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Irvine

Showing results (391-400 of 610) with videos related to

Pageof 61
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 5, 2021
Clinical examination for hyperlinear palms to determine filaggrin genotype: A diagnostic test accuracy studyLucy E Bradshaw, Rachel H Haines, Kim S Thomas, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2023
The role of Janus kinase signaling in the pathology of atopic dermatitisEmma Guttman-Yassky, Alan D Irvine, Patrick M Brunner, et al.
American Journal of Clinical Dermatology|April 17, 2026
Identifying the Most Relevant Eczema Area and Severity Index Thresholds from the Patient Perspective in Atopic Dermatitis TreatmentLawrence F Eichenfield, Peter A Lio, Alan D Irvine, et al.
Advances in Therapy|June 22, 2023
Correction to: A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19Thomas Bieber, Eugen Feist, Alan D Irvine, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 13, 2019
Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey-based position statementY A Leshem, R Bissonnette, C Paul, et al.
Advances in Therapy|September 5, 2022
A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19Thomas Bieber, Eugen Feist, Alan D Irvine, et al.
Cardiovascular Surgery (London, England)|April 1, 1997
Activated protein C resistance, factor V Leiden and peripheral vascular diseaseP W Foley, C D Irvine, G R Standen, et al.
Glycoconjugate Journal|September 19, 2007
Distinct contributions of beta 4GalNAcTA and beta 4GalNAcTB to Drosophila glycosphingolipid biosynthesisAnita Stolz, Nicola Haines, Andreas Pich, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 18, 2025
Erratum to 'Highly accurate, noninvasive early identification of infants with a filaggrin loss-of-function mutation by in vivo Raman spectroscopy, followed from birth to 12 months' [Annals of Allergy, Asthma & Immunology, 134;4 (2025) 457-464]Gerwin J Puppels, Jonathan O'B Hourihane, Claudio Nico, et al.
Development (Cambridge, England)|February 10, 2011
Characterization of a Dchs1 mutant mouse reveals requirements for Dchs1-Fat4 signaling during mammalian developmentYaopan Mao, Joanna Mulvaney, Sana Zakaria, et al.
Pageof 61

Showing results (391-400 of 610) with videos related to

Sort By:
Pageof 61
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 5, 2021
Clinical examination for hyperlinear palms to determine filaggrin genotype: A diagnostic test accuracy studyLucy E Bradshaw, Rachel H Haines, Kim S Thomas, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2023
The role of Janus kinase signaling in the pathology of atopic dermatitisEmma Guttman-Yassky, Alan D Irvine, Patrick M Brunner, et al.
American Journal of Clinical Dermatology|April 17, 2026
Identifying the Most Relevant Eczema Area and Severity Index Thresholds from the Patient Perspective in Atopic Dermatitis TreatmentLawrence F Eichenfield, Peter A Lio, Alan D Irvine, et al.
Advances in Therapy|June 22, 2023
Correction to: A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19Thomas Bieber, Eugen Feist, Alan D Irvine, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 13, 2019
Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey-based position statementY A Leshem, R Bissonnette, C Paul, et al.
Advances in Therapy|September 5, 2022
A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19Thomas Bieber, Eugen Feist, Alan D Irvine, et al.
Cardiovascular Surgery (London, England)|April 1, 1997
Activated protein C resistance, factor V Leiden and peripheral vascular diseaseP W Foley, C D Irvine, G R Standen, et al.
Glycoconjugate Journal|September 19, 2007
Distinct contributions of beta 4GalNAcTA and beta 4GalNAcTB to Drosophila glycosphingolipid biosynthesisAnita Stolz, Nicola Haines, Andreas Pich, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 18, 2025
Erratum to 'Highly accurate, noninvasive early identification of infants with a filaggrin loss-of-function mutation by in vivo Raman spectroscopy, followed from birth to 12 months' [Annals of Allergy, Asthma & Immunology, 134;4 (2025) 457-464]Gerwin J Puppels, Jonathan O'B Hourihane, Claudio Nico, et al.
Development (Cambridge, England)|February 10, 2011
Characterization of a Dchs1 mutant mouse reveals requirements for Dchs1-Fat4 signaling during mammalian developmentYaopan Mao, Joanna Mulvaney, Sana Zakaria, et al.
Pageof 61